JAMA Intern Med:年龄因素对慢性肾病诊断率的影响

2021-09-02 MedSci原创 MedSci原创

相同的慢性肾病诊断标准高估了高龄老人的慢性肾病负担

慢性肾病(CKD)是一个全球性的公共卫生挑战,目前对于成人CKD的诊断是基于肾结构或功能 (蛋白尿或肾小球滤过率) 异常,通常不考虑年龄对于肾功能的影响,这导致许多因生理或与年龄相关的eGFR下降的正常老年人被归类于CKD患者。近日研究人员考察了在CKD诊断过程中考虑年龄因素对临床诊断的影响。 本次以人群为基础的队列研究在加拿大开展,固定CKD诊断标准为eGFR低于60ml/min/1.73m2,持续超过3个月,而年龄调整的CKD诊断标准为:40岁以下、40-64岁人群以及65岁以上人群分别为eGFR低于75、60以及45 ml/min/1.73m2。研究的主要终点为肾衰竭发病率(肾脏替代治疗或持续3个月以上eGFR<15 mL/min/1.73 m2)以及无肾衰竭死亡率。 固定阈值队列包含127132名参与者,其中女性占54.7%,年龄调整队列包含81209名参与者,女性占54.9%,随访中,每100000随访年分别发生537例以及343例肾衰竭事件。固定阈值队列中肾衰竭(5年发生率1.7% vs 3.0%)发生率以及死亡率(21.9% vs 25.4%)低于年龄调整队列组,但

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2171371, encodeId=581121e13715b, content=好<a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53642, encryptionId=f6f5536422e, topicName=慢性肾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c811586618, createdName=zhangxy712, createdTime=Mon Nov 27 23:00:43 CST 2023, time=2023-11-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1981638, encodeId=12211981638f0, content=<a href='/topic/show?id=87679163e47' target=_blank style='color:#2F92EE;'>#诊断率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91637, encryptionId=87679163e47, topicName=诊断率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfe313, createdName=charleshjw, createdTime=Tue Jun 28 08:44:28 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611239, encodeId=d3111611239b2, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Sep 04 09:44:28 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014162, encodeId=990a1014162dc, content=好<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d275455878, createdName=ms1000001757407963, createdTime=Fri Sep 03 05:05:40 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036814, encodeId=9e48103681464, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Sep 02 21:44:28 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013861, encodeId=9b10101386155, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43d25501695, createdName=ms6000001608459305, createdTime=Thu Sep 02 19:31:08 CST 2021, time=2021-09-02, status=1, ipAttribution=)]
    2023-11-27 zhangxy712 来自上海
  2. [GetPortalCommentsPageByObjectIdResponse(id=2171371, encodeId=581121e13715b, content=好<a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53642, encryptionId=f6f5536422e, topicName=慢性肾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c811586618, createdName=zhangxy712, createdTime=Mon Nov 27 23:00:43 CST 2023, time=2023-11-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1981638, encodeId=12211981638f0, content=<a href='/topic/show?id=87679163e47' target=_blank style='color:#2F92EE;'>#诊断率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91637, encryptionId=87679163e47, topicName=诊断率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfe313, createdName=charleshjw, createdTime=Tue Jun 28 08:44:28 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611239, encodeId=d3111611239b2, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Sep 04 09:44:28 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014162, encodeId=990a1014162dc, content=好<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d275455878, createdName=ms1000001757407963, createdTime=Fri Sep 03 05:05:40 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036814, encodeId=9e48103681464, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Sep 02 21:44:28 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013861, encodeId=9b10101386155, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43d25501695, createdName=ms6000001608459305, createdTime=Thu Sep 02 19:31:08 CST 2021, time=2021-09-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2171371, encodeId=581121e13715b, content=好<a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53642, encryptionId=f6f5536422e, topicName=慢性肾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c811586618, createdName=zhangxy712, createdTime=Mon Nov 27 23:00:43 CST 2023, time=2023-11-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1981638, encodeId=12211981638f0, content=<a href='/topic/show?id=87679163e47' target=_blank style='color:#2F92EE;'>#诊断率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91637, encryptionId=87679163e47, topicName=诊断率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfe313, createdName=charleshjw, createdTime=Tue Jun 28 08:44:28 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611239, encodeId=d3111611239b2, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Sep 04 09:44:28 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014162, encodeId=990a1014162dc, content=好<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d275455878, createdName=ms1000001757407963, createdTime=Fri Sep 03 05:05:40 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036814, encodeId=9e48103681464, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Sep 02 21:44:28 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013861, encodeId=9b10101386155, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43d25501695, createdName=ms6000001608459305, createdTime=Thu Sep 02 19:31:08 CST 2021, time=2021-09-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2171371, encodeId=581121e13715b, content=好<a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53642, encryptionId=f6f5536422e, topicName=慢性肾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c811586618, createdName=zhangxy712, createdTime=Mon Nov 27 23:00:43 CST 2023, time=2023-11-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1981638, encodeId=12211981638f0, content=<a href='/topic/show?id=87679163e47' target=_blank style='color:#2F92EE;'>#诊断率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91637, encryptionId=87679163e47, topicName=诊断率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfe313, createdName=charleshjw, createdTime=Tue Jun 28 08:44:28 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611239, encodeId=d3111611239b2, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Sep 04 09:44:28 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014162, encodeId=990a1014162dc, content=好<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d275455878, createdName=ms1000001757407963, createdTime=Fri Sep 03 05:05:40 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036814, encodeId=9e48103681464, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Sep 02 21:44:28 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013861, encodeId=9b10101386155, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43d25501695, createdName=ms6000001608459305, createdTime=Thu Sep 02 19:31:08 CST 2021, time=2021-09-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2171371, encodeId=581121e13715b, content=好<a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53642, encryptionId=f6f5536422e, topicName=慢性肾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c811586618, createdName=zhangxy712, createdTime=Mon Nov 27 23:00:43 CST 2023, time=2023-11-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1981638, encodeId=12211981638f0, content=<a href='/topic/show?id=87679163e47' target=_blank style='color:#2F92EE;'>#诊断率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91637, encryptionId=87679163e47, topicName=诊断率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfe313, createdName=charleshjw, createdTime=Tue Jun 28 08:44:28 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611239, encodeId=d3111611239b2, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Sep 04 09:44:28 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014162, encodeId=990a1014162dc, content=好<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d275455878, createdName=ms1000001757407963, createdTime=Fri Sep 03 05:05:40 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036814, encodeId=9e48103681464, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Sep 02 21:44:28 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013861, encodeId=9b10101386155, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43d25501695, createdName=ms6000001608459305, createdTime=Thu Sep 02 19:31:08 CST 2021, time=2021-09-02, status=1, ipAttribution=)]
    2021-09-02 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2171371, encodeId=581121e13715b, content=好<a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53642, encryptionId=f6f5536422e, topicName=慢性肾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c811586618, createdName=zhangxy712, createdTime=Mon Nov 27 23:00:43 CST 2023, time=2023-11-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1981638, encodeId=12211981638f0, content=<a href='/topic/show?id=87679163e47' target=_blank style='color:#2F92EE;'>#诊断率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91637, encryptionId=87679163e47, topicName=诊断率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfe313, createdName=charleshjw, createdTime=Tue Jun 28 08:44:28 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611239, encodeId=d3111611239b2, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Sep 04 09:44:28 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014162, encodeId=990a1014162dc, content=好<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d275455878, createdName=ms1000001757407963, createdTime=Fri Sep 03 05:05:40 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036814, encodeId=9e48103681464, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Sep 02 21:44:28 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013861, encodeId=9b10101386155, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43d25501695, createdName=ms6000001608459305, createdTime=Thu Sep 02 19:31:08 CST 2021, time=2021-09-02, status=1, ipAttribution=)]
    2021-09-02 ms6000001608459305

    0

相关资讯

Ann Otol Rhinol Laryngol:烟花爆竹相关的耳鼻喉科创伤

在美国,烟花普遍用于庆祝活动,但会导致头部和颈部的严重伤害。

Clin Gastroenterology H: 早期和晚期特发性慢性胰腺炎患者在症状发作时的年龄差异和遗传变异的影响

慢性胰腺炎(CP)是关于胰腺炎症和胰腺功能障碍的综合征,是一个世界性的那题。较早的研究表明,绝大多数患者都是重度饮酒的男性。

Am Heart J:新一代药物洗脱支架可有效且安全的治疗年龄大于80岁的老年患者

目前,关于80岁以上老年患者经常接受新一代药物洗脱支架(DES)治疗的疗效和安全性数据不足。近日,研究人员评估了使用新一代DES治疗的80岁以上老年患者与年轻患者的1年临床结果,研究结果已发表于Am

Stroke:女性 vs. 男性的卒中和短暂性脑缺血发作风险差异取决于年龄

与男性相比,女性患卒中或短暂性脑缺血(TIA)发作的风险总体较低。然而,只有40-80岁人群中观察到女性的风险较低。在30岁以下的人群中,女性卒中/TIA风险高于男性。

Br J Cancer:观察性队列研究揭示化疗对早期乳腺癌老年患者的影响

在2014–2016年期间,英国每年有超过18,500名年龄在70岁以上的女性被诊断出患有乳腺癌,占所有确诊患者的34%。